OTCMKTS:GNGBY Getinge (GNGBY) Stock Price, News & Analysis $26.88 -0.39 (-1.44%) As of 11/20/2026 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsNews and TrendsShort Interest About Getinge Stock (OTCMKTS:GNGBY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Getinge alerts:Sign Up Key Stats Today's Range$26.73▼$26.8950-Day Range$23.93▼$28.7052-Week Range$18.99▼$28.83Volume621 shsAverage Volume583 shsMarket Capitalization$7.32 billionP/E Ratio24.43Dividend Yield1.08%Price TargetN/AConsensus RatingHold Company Overview Getinge is a Swedish medical technology company that develops products and services for hospitals and life science organizations. Its offerings support patient care, surgical procedures, infection prevention and the production of medicines and other biological products. The company’s portfolio includes equipment and solutions for intensive care, cardiovascular procedures and operating rooms, as well as sterilization and cleaning systems. Its life science business provides solutions used in areas such as pharmaceutical and biotechnology manufacturing. Founded in 1904 in the Swedish town of Getinge, the company is headquartered in Gothenburg and serves customers in markets around the world. Mattias Perjos has served as Getinge’s president and chief executive officer since 2017.AI Generated. May Contain Errors. Read More Receive GNGBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Getinge and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNGBY Stock News HeadlinesGetinge Establishes Sustainable Financing FrameworkNovember 12, 2026 | tipranks.comGetinge Appoints Stacy Beske to Lead Acute Care TherapiesNovember 9, 2026 | tipranks.comWhoops! I wasn’t supposed to share this with you yetTraders have paid as much as $500 for technology like this. Thomas Wood of Base Camp Trading is offering his proprietary Snapback Indicator for just $7. There is no subscription and no recurring charge, and it's yours for life. The indicator is designed to help identify potential market turning points, showing when it may be time to buy, sell, or go short.November 22 at 1:00 AM | Base Camp Trading (Ad)Getinge Announces Leadership Change in Acute Care Therapies DivisionOctober 26, 2026 | tipranks.comGetinge AB Earnings Call Signals Steady Margin ClimbOctober 25, 2026 | tipranks.comGetinge AB Earnings Call: Margins Rise Amid HeadwindsOctober 21, 2026 | tipranks.comGetinge Industrier AB ADR Stock Price HistoryOctober 21, 2026 | investing.comGetinge lifts margins and cash flow as new critical-care products roll outOctober 21, 2026 | tipranks.comSee More Headlines GNGBY Stock Analysis - Frequently Asked Questions How have GNGBY shares performed this year? Getinge's stock was trading at $23.65 on January 1st, 2026. Since then, GNGBY shares have increased by 13.6% and is now trading at $26.8750. How were Getinge's earnings last quarter? Getinge (OTCMKTS:GNGBY) issued its quarterly earnings results on Wednesday, October, 21st. The company reported $0.32 earnings per share (EPS) for the quarter. The business had revenue of $875.58 million for the quarter. Getinge had a trailing twelve-month return on equity of 11.42% and a net margin of 8.20%. How do I buy shares of Getinge? Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings10/21/2026Today11/22/2026Fiscal Year End12/31/2026Next Earnings (Estimated)1/26/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:GNGBY CIKN/A Webwww.getinge.com Phone(610) 335-0000Fax46-1-033-556-40Employees11,670Year Founded1904Profitability EPS (Trailing Twelve Months)$1.10 Trailing P/E Ratio24.43 Forward P/E Ratio18.28 P/E GrowthN/ANet Income$230.87 million Net Margins8.20% Pretax Margin11.19% Return on Equity11.42% Return on Assets6.13% Debt Debt-to-Equity Ratio0.21 Current Ratio1.25 Quick Ratio0.74 Sales & Book Value Annual Sales$3.57 billion Price / Sales2.05 Cash Flow$2.01 per share Price / Cash Flow13.37 Book Value$12.45 per share Price / Book2.16Miscellaneous Outstanding Shares272,370,000Free FloatN/AMarket Cap$7.32 billion OptionableNot Optionable Beta0.89 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:GNGBY) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Getinge Please log in to your account or sign up in order to add this asset to your watchlist. Share Getinge With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.